4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0000950170-25-032309
EVP, Chief Development Officer acquired 9,583 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Poulton Stuart EVP, Chief Development Officer | 2025-02-28 | Grant or award | +5,000 | 26,379 | D | ||
| Poulton Stuart EVP, Chief Development Officer | 2025-02-28 | Grant or award | +4,583 | 30,962 | D | ||
| Derivatives | |||||||
| Poulton Stuart EVP, Chief Development Officer | 2025-02-28 | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | D | ||
| Poulton Stuart EVP, Chief Development Officer | 2025-02-28 | Grant or award · Stock Option (right to buy) | +9,166 | 9,166 | D | ||
Loading xslF345X05/ownership.xml…